Curettage of Benign Bone Tumors Without Grafts Gives Sufficient Bone Strength

Overview

Journal Acta Orthop

Specialty Orthopedics

Date 2009 Feb 24

PMID 19234882

Citations 27

Authors

Takashi Yanagawa

Hideomi Watanabe

Tetsuya Shinozaki

Kenji Takagishi

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: The defect that results after curettage of a bone tumor is usually filled in the same way. We report the outcome in patients with benign bone tumors that were treated with curettage but no filling.

Patients And Methods: We retrospectively studied 78 patients (mean age at the time of operation was 27 (6-73) years, 44 men) who had had a benign bone tumor curetted with no filling of the defect. The commonest tumor types were giant cell tumor of bone (27), fibrous dysplasia (13), enchondroma (9), and simple bone cyst (7). The mean size of the lesions was 35 (2-196) cm(3). Normal activities, including full weight bearing for lower extremity lesions, were allowed after 3 months or less. The patients were followed for an average of 10 (1.2-21) years.

Results: A postoperative fracture with a minor displacement occurred in 3 patients, in 2 of them because of local recurrence. All fractures healed. Local recurrence occurred in 9 patients; 7 of them had a giant cell tumor. Repeated local recurrences necessitated above-knee amputation in 1 patient. All other patients had unrestricted activities of daily living.

Interpretation: Routine filling of curetted bone lesions does not appear to be necessary from a mechanical point of view.

Citing Articles

Clinical Application of Unidirectional Porous Hydroxyapatite to Bone Tumor Surgery and Other Orthopedic Surgery.

Kunisada T, Nakata E, Fujiwara T, Hata T, Sato K, Katayama H Biomimetics (Basel). 2024; 9(5).

PMID: 38786504 PMC: 11117865. DOI: 10.3390/biomimetics9050294.

Fracture risk after intralesional curettage of atypical cartilaginous tumors.

Krebbekx G, Fris F, Schaap G, Bramer J, Verspoor F, Janssen S J Orthop Surg Res. 2023; 18(1):851.

PMID: 37946306 PMC: 10634173. DOI: 10.1186/s13018-023-04215-4.

Is three-dimension-printed mesh scaffold an alternative to reconstruct cavity bone defects near joints?.

Gong T, Lu M, Wang J, Zhang Y, Wang Y, Li Z Int Orthop. 2023; 47(3):631-639.

PMID: 36629849 DOI: 10.1007/s00264-022-05684-8.

Imaging following surgery for primary appendicular bone tumours.

Khan I, Gerrand C, Saifuddin A Skeletal Radiol. 2021; 50(8):1527-1555.

PMID: 33481074 DOI: 10.1007/s00256-021-03712-z.

Which one of the benign tumors and tumor-like lesions located in long bones needs prophylactic fixation during surgery?.

Togral G, Yapar A, Tolunay T Jt Dis Relat Surg. 2021; 32(1):210-217.

PMID: 33463439 PMC: 8073453. DOI: 10.5606/ehc.2020.75064.

References

Turcotte R, Wunder J, Isler M, Bell R, Schachar N, Masri B . Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002; (397):248-58. DOI: 10.1097/00003086-200204000-00029. View

Hirata M, Murata H, Takeshita H, Sakabe T, Tsuji Y, Kubo T . Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours. Int Orthop. 2006; 30(6):510-3. PMC: 3172745. DOI: 10.1007/s00264-006-0156-1. View

Frassica F, Sim F, Pritchard D, Chao E . Subchondral replacement: a comparative analysis of reconstruction with methyl methacrylate or autogenous bone graft. Chir Organi Mov. 1990; 75(1 Suppl):189-90. View

Kivioja A, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer H . Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008; 79(1):86-93. DOI: 10.1080/17453670710014815. View

Bini S, Gill K, Johnston J . Giant cell tumor of bone. Curettage and cement reconstruction. Clin Orthop Relat Res. 1995; (321):245-50. View

Hasselgren G, FORSSBLAD P, Tornvall A . Bone grafting unnecessary in the treatment of enchondromas in the hand. J Hand Surg Am. 1991; 16(1):139-42. DOI: 10.1016/s0363-5023(10)80031-0. View

Campanacci M, Capanna R, Fabbri N, Bettelli G . Curettage of giant cell tumor of bone. Reconstruction with subchondral grafts and cement. Chir Organi Mov. 1990; 75(1 Suppl):212-3. View

ODonnell R, Springfield D, Motwani H, Ready J, Gebhardt M, Mankin H . Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994; 76(12):1827-33. DOI: 10.2106/00004623-199412000-00009. View

Mjoberg B, Pettersson H, Rosenqvist R, Rydholm A . Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand. 1984; 55(6):597-600. DOI: 10.3109/17453678408992403. View

10.

Blackley H, Wunder J, Davis A, White L, Kandel R, Bell R . Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999; 81(6):811-20. DOI: 10.2106/00004623-199906000-00008. View

11.

Itokazu M, Matsunaga T, Ishii M, Kusakabe H, Wyni Y . Use of arthroscopy and interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Arch Orthop Trauma Surg. 1996; 115(1):45-8. DOI: 10.1007/BF00453217. View

12.

Matsumine A, Myoui A, Kusuzaki K, Araki N, Seto M, Yoshikawa H . Calcium hydroxyapatite ceramic implants in bone tumour surgery. A long-term follow-up study. J Bone Joint Surg Br. 2004; 86(5):719-25. DOI: 10.1302/0301-620x.86b5.14242. View

13.

Aspenberg P . Black holes in bone - irresistible attractors of foreign materials?. Acta Orthop. 2009; 80(1):2-3. PMC: 2823249. DOI: 10.1080/17453670902804489. View

14.

Grandjean-Laquerriere A, Tabary O, Jacquot J, Richard D, Frayssinet P, Guenounou M . Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials. 2006; 28(3):400-4. DOI: 10.1016/j.biomaterials.2006.09.015. View

15.

Malawer M, MARKS M, McChesney D, Piasio M, Gunther S, Schmookler B . The effect of cryosurgery and polymethylmethacrylate in dogs with experimental bone defects comparable to tumor defects. Clin Orthop Relat Res. 1988; (226):299-310. View

16.

Hamson K, Toth J, Stiehl J, Lynch K . Preliminary experience with a novel model assessing in vivo mechanical strength of bone grafts and substitute materials. Calcif Tissue Int. 1995; 57(1):64-8. DOI: 10.1007/BF00298999. View

17.

Laquerriere P, Grandjean-Laquerriere A, Jallot E, Balossier G, Frayssinet P, Guenounou M . Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro. Biomaterials. 2003; 24(16):2739-47. DOI: 10.1016/s0142-9612(03)00089-9. View

18.

Kaelin A, Emans J . En-bloc resection for proximal humerus osteogenic sarcoma. Z Kinderchir. 1985; 40(4):217-20. DOI: 10.1055/s-2008-1059777. View

19.

Wada T, Kaya M, Nagoya S, Kawaguchi S, Isu K, Yamashita T . Complications associated with bone cementing for the treatment of giant cell tumors of bone. J Orthop Sci. 2002; 7(2):194-8. DOI: 10.1007/s007760200033. View

20.

Campanacci M, Laus M . Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg Am. 1981; 63(3):367-75. View